While its prompt administration of tPA following stroke onset has been shown to improve clinical outcomes, its use is limited due to an increased risk of intracranial hemorrhage when tPA is used after the recommended 3 h therapeutic window, which can negate the potential benefits of vascular recanalization. Here, PLAT is linked to stroke disorder.